Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

NCT04588077 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B
Cirrhosis, Liver
Chronic Liver Disease

Interventions

BIOLOGICAL: Heplisav-B Injectable Product, 2-dose regimen
BIOLOGICAL: Heplisav-B Injectable Product, 3-dose regimen

Sponsor

Mercy Medical Center